Posted on
Oct 4, 2026
Documenting G2211 Longitudinal Focal Point Attestation in Ambient AI Notes (2026 Playbook)
Documenting G2211 Longitudinal Focal Point Attestation in Ambient AI Primary Care Notes: A 2026 Operations Playbook
G2211 rewards relationships, not visits. The add-on code recognizes the cognitive work of being the physician a patient returns to, but auditors cannot see a relationship. They can only see what the note states, and most ambient drafts do not state it explicitly. This playbook, written by the clinical team at Scribing.io, sets out the documentation logic, billing rules, and workflow controls required to make that relationship visible and defensible.
This guide is for DPC physicians. It applies to direct primary care physicians who run hybrid models, see Medicare-age members, or bill some payers while keeping membership revenue for the rest. It reflects how Scribing.io and the Merry AI Clinical Interface handle G2211 attestation, Modifier 25 collisions, and EHR injection. Each section is built from claim-level failure patterns rather than marketing claims.
What G2211 Requires in 2026
The Modifier 25 Collision Problem
Clinical Scenario: HFrEF, T2DM, Injection
Anatomy of Compliant Attestation
Clinical Logic Bridge Defends Modifier 25
The $15,600 Clawback Math
Epic DOM Tab-Injection Workflow
DPC Billing Models and G2211
ICD-10 Specificity for Both Conditions
Failure Modes Auditors Flag First
Consent, State Law, and Oversight
Implementation Checklist for DPC Practices
Plans and Practical Next Steps
What G2211 Actually Requires in 2026
The code descriptor is precise. HCPCS G2211 describes visit complexity inherent to office and outpatient E/M services that serve as the continuing focal point for all needed health care services, or that are part of ongoing care for a single serious or complex condition. It is an add-on only to CPT 99202–99205 and 99211–99215. It carries no separate time requirement and no standalone medical decision-making threshold.
CMS did not script language. CMS has not mandated a specific attestation phrase. Its G2211 FAQ, and Medicare Administrative Contractor guidance including Noridian's published Q&A, indicate that the medical record should support the longitudinal relationship and the ongoing nature of the care. In practice, that means two things must be legible to a reviewer who has never met the patient.
An explicit longitudinal statement naming the practitioner as the continuing focal point, or tying the visit to ongoing care of a serious or complex condition.
A forward-looking management plan showing the physician will continue to own decisions after this encounter, not merely address a one-time problem.
Rule Element | Current Medicare Position | Documentation Implication |
|---|---|---|
Eligible base codes | 99202–99205, 99211–99215 | Not reportable with preventive-only or procedure-only visits |
Relationship basis | Focal point OR ongoing serious/complex condition | State which basis applies, by name |
New patient use | Permitted if relationship is intended to continue | Document the intended ongoing role at visit one |
Modifier 25 on base E/M | Not payable, except with AWV, vaccine administration, or Part B preventive service | Minor procedures such as 20610 block payment |
Typical reimbursement | Roughly $16 national non-facility; varies by locality | Small per claim, material across a panel |
Verify locally every January. Confirm current G2211 policy against your MAC's article and the final Physician Fee Schedule.
The Modifier 25 Collision Every DPC Physician Faces
Same-day procedures change the claim. When a physician performs a minor procedure and a significant, separately identifiable E/M on the same day, the E/M carries Modifier 25. Since the CY2025 rule, CMS pays G2211 with a Modifier 25 E/M only when the other same-day service is an annual wellness visit, vaccine administration, or a Medicare Part B preventive service. A trochanteric bursa injection (CPT 20610) is none of those.
Two separate risks emerge here. The first is a line-level G2211 denial, typically returned as a bundling adjustment. The second is far more expensive: a post-payment review concluding the E/M was never separately identifiable, which reverses the Modifier 25 E/M itself and can be extrapolated across a sample.
Line-level denial is cheap. It costs one G2211 payment and some rework.
Modifier 25 reversal is expensive. It removes the full E/M payment and invites extrapolation.
Both share one root cause. The note fails to separate procedural work from chronic disease management.
Ambient drafts blur the boundary. A conversation moves naturally between hip pain, potassium levels, and glucose trends. Unless the documentation engine deliberately partitions those threads, the resulting note reads as one blended visit, which is exactly what reviewers are trained to reject.
Clinical Scenario: HFrEF, T2DM, and a Same-Day Bursa Injection
The encounter is common enough. A direct primary care physician, Dr. Rivera, sees a 68-year-old member with heart failure with reduced ejection fraction (LVEF 35%) and type 2 diabetes for longitudinal medication management. During the visit, the patient reports lateral hip pain, and Dr. Rivera performs a same-day right greater trochanteric bursa injection.
Clinical Thread | Key Facts Captured | Billing Relevance |
|---|---|---|
HFrEF | LVEF 35% on prior TTE; NYHA class II; GDMT not at target | Chronic illness not at goal; prescription drug management |
GDMT history | Lisinopril stopped for cough; losartan uptitration limited by SBP 94; empagliflozin stopped after recurrent genital mycotic infection | Documents failed optimization steps and escalating complexity |
T2DM with hyperglycemia | A1c 8.4%; 14-day CGM time-in-range 52%, GMI 7.9% | Second chronic illness not at goal; data review |
Trochanteric bursitis | Right side; triamcinolone 40 mg with 1% lidocaine | CPT 20610 plus drug supply; 0-day global |
Merry AI drafts the assessment. The ambient engine produces an assessment and plan from the conversation. The Clinical Intelligence Layer then detects longitudinal continuity signals: prior titration history, a standing follow-up cadence, and Dr. Rivera's role coordinating cardiology and endocrinology input.
Two engines run in parallel. The Clinical Intelligence Layer auto-generates a G2211 attestation naming Dr. Rivera as the continuing focal point and detailing the CHF uptitration and CGM-guided diabetes plan. Simultaneously, the Clinical Logic Bridge cites LVEF 35% and the failed ACE/ARB and SGLT2 inhibitor steps to justify the separate E/M with Modifier 25.
One clarification on SGLT2 inhibitors. They are fixed-dose; the engine records intolerance, not failed dose escalation.
Anatomy of a Compliant Longitudinal Attestation
Generic templates fail under review. Phrases such as "patient established with practice" do not describe a focal-point relationship. The attestation must name the practitioner, identify the relationship basis, and connect it to a specific plan that extends beyond today.
Sample attestation, as injected: "I, Dr. Rivera, serve as this patient's continuing focal point for all needed health care services, including coordination of cardiology and endocrinology recommendations. Today's visit is part of ongoing management of chronic systolic heart failure (LVEF 35%) and type 2 diabetes with hyperglycemia."
Ongoing plan, heart failure: "Losartan uptitration remains limited by SBP 94; transition directly to sacubitril/valsartan 24/26 mg twice daily (no washout required from ARB). Continue carvedilol and spironolactone; BMP in 7–10 days; reassess volume status and titration at a two-week follow-up I will conduct."
Ongoing plan, diabetes care: "CGM-guided plan targeting time-in-range above 70% with time-below-range under 4%. Continue GLP-1 receptor agonist titration; I will review the next 14-day CGM report in four weeks and adjust therapy."
Attestation Element | Why Reviewers Look for It | Engine Source |
|---|---|---|
Named practitioner | Establishes who owns the relationship | Encounter provider plus continuity history |
Relationship basis | Matches the G2211 descriptor language | Clinical Intelligence Layer classification |
Condition specificity | Shows serious or complex condition | Problem list mapped to ICD-10-CM |
Future-dated actions | Proves ongoing, not episodic, care | Plan extraction from transcript |
Coordination role | Supports "all needed services" language | Referral and consult mentions |
The physician still signs it. The engine drafts; it does not attest. Dr. Rivera reviews the language, edits anything inaccurate, and signs, which keeps legal authorship and clinical accountability where they belong.
How the Clinical Logic Bridge Defends Modifier 25
Separation must be affirmative, explicit. CPT 20610 includes the decision to perform the injection and routine pre- and post-procedure work. The E/M must stand on its own, so the Clinical Logic Bridge builds the Modifier 25 justification exclusively from non-procedural elements.
MDM Component | Evidence Cited | Level Supported |
|---|---|---|
Problems addressed | Two chronic illnesses not at goal: HFrEF with LVEF 35% and T2DM with A1c 8.4% | Moderate |
Data reviewed | BMP with potassium, 14-day CGM report, prior echocardiogram | Limited to moderate |
Risk of management | Prescription drug management: ARB-to-ARNI transition, GLP-1 RA titration | Moderate |
Resulting E/M | 99214 with Modifier 25 | Separately identifiable |
Some content is deliberately excluded. Counseling about transient steroid-related hyperglycemia after triamcinolone is clinically important, and the engine links it to CGM alert thresholds. However, the Bridge assigns that counseling to the procedure note, because a reviewer could reasonably classify it as post-procedure work.
Procedure note stands alone. Indication, laterality, consent, landmark technique, drug, dose, lot, and immediate tolerance.
E/M note stands alone. Chronic disease assessment, data review, medication changes, and follow-up ownership.
Diagnosis pointers stay separate. M70.61 links to 20610; I50.22 and E11.65 link to 99214.
G2211 capture remains compliant. For a traditional Medicare claim carrying 99214-25 with 20610, the Bridge withholds G2211 from that claim to prevent a predictable denial. The signed attestation stays in the record, and G2211 is captured at the two-week titration visit, which carries no Modifier 25.
Never split visits for revenue. Deferring medically appropriate same-day care to capture G2211 is not compliant practice.
The $15,600 Clawback Math, Line by Line
The projection uses conservative inputs. The figure models a twelve-month post-payment review of a hybrid DPC practice's Modifier 25 E/M claims where notes blended procedural and chronic care work. It is illustrative, and practices should substitute their own volumes and local fee schedule rates.
Variable | Value | Basis |
|---|---|---|
Modifier 25 E/M claims in review period | 120 | Approximately 10 same-day procedure visits per month |
Average allowed amount per 99214 | $130 | Approximate national non-facility rate |
Assumed error rate on blended notes | 100% of sampled claims | Worst case when separation is absent |
Projected recoupment | $15,600 |



